{"data":{"billId":"118-hr-3839","congress":118,"type":"HR","number":"3839","title":"To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.","shortTitle":null,"originChamber":"House","introducedDate":"2023-06-06","updateDate":"2024-07-24T15:21:45Z","latestAction":{"actionDate":"2023-06-09","text":"Referred to the Subcommittee on Health."},"policyArea":"Health","sponsors":[{"bioguideId":"D000628","district":2,"firstName":"Neal","fullName":"Rep. Dunn, Neal P. [R-FL-2]","isByRequest":"N","lastName":"Dunn","middleName":"P.","party":"R","state":"FL","url":"https://api.congress.gov/v3/member/D000628?format=json"}],"cosponsorsCount":1,"committeesCount":1,"actionsCount":4,"textVersionsCount":1,"url":"https://civdotiq.org/bill/118-hr-3839"},"meta":{"apiVersion":"v1","timestamp":"2026-10-04T05:08:04.060Z","source":"congress.gov","license":"MIT","documentation":"https://civdotiq.org/docs/api"}}